- Home
- UCTT vs OCS Comparison
UCTT vs OCS Comparison
Compare UCTT & OCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UCTT
- OCS
- Stock Information
- Founded
- UCTT 1991
- OCS 2003
- Country
- UCTT United States
- OCS Switzerland
- Employees
- UCTT N/A
- OCS N/A
- Industry
- UCTT Semiconductors
- OCS Biotechnology: Pharmaceutical Preparations
- Sector
- UCTT Technology
- OCS Health Care
- Exchange
- UCTT Nasdaq
- OCS Nasdaq
- Market Cap
- UCTT 1.0B
- OCS 1.0B
- IPO Year
- UCTT 2004
- OCS N/A
- Fundamental
- Price
- UCTT $25.26
- OCS $19.00
- Analyst Decision
- UCTT Strong Buy
- OCS Strong Buy
- Analyst Count
- UCTT 4
- OCS 3
- Target Price
- UCTT $43.25
- OCS $35.33
- AVG Volume (30 Days)
- UCTT 621.0K
- OCS 27.1K
- Earning Date
- UCTT 07-24-2025
- OCS 08-26-2025
- Dividend Yield
- UCTT N/A
- OCS N/A
- EPS Growth
- UCTT N/A
- OCS N/A
- EPS
- UCTT 0.62
- OCS N/A
- Revenue
- UCTT $2,138,500,000.00
- OCS $847,333.00
- Revenue This Year
- UCTT N/A
- OCS $18.70
- Revenue Next Year
- UCTT $1.85
- OCS $1,059.78
- P/E Ratio
- UCTT $41.04
- OCS N/A
- Revenue Growth
- UCTT 20.21
- OCS N/A
- 52 Week Low
- UCTT $16.66
- OCS $10.79
- 52 Week High
- UCTT $56.47
- OCS $23.08
- Technical
- Relative Strength Index (RSI)
- UCTT 71.48
- OCS 46.89
- Support Level
- UCTT $22.00
- OCS $18.87
- Resistance Level
- UCTT $22.93
- OCS $19.75
- Average True Range (ATR)
- UCTT 0.99
- OCS 0.43
- MACD
- UCTT 0.47
- OCS -0.11
- Stochastic Oscillator
- UCTT 94.73
- OCS 32.43
About UCTT Ultra Clean Holdings Inc.
Ultra Clean Holdings Inc, through its subsidiaries, manufactures and supplies production tools, modules, and subsystems for the semiconductor capital equipment industry. The product includes precision robotic solutions, gas delivery systems, and a variety of industrial and automation production equipment products; subsystems include wafer cleaning subsystems, chemical delivery modules, top-plate assemblies, frame assemblies, and process modules. Its customer base includes firms in the semiconductor capital equipment industry, medical, energy, industrial, flat panel, and research equipment industries. It has two segments Products and Services. Its principal markets are Americas, Asia Pacific and EMEA.
About OCS Oculis Holding AG Ordinary shares
Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.